$150K fine for Aussie Code breach

Posted 25 March 2024 PM

Janssen has been fined $150,000 for breaching the Medicines Australia Code of Conduct after Bayer complained about a claim made in promotional material relating to prostate cancer drug Eryland, which it believed could have a significant impact on prescribing.

The claim made in a one-page advertisement or banner/conference panel was that: "Erlyand reduces the relative risk of death by 48 per cent in a broad mHSPC patient population (OS [overall survival] after cross over correction HR=0.52; p<0.0001, in combination with ADT)."

To see the whole article, please login